Co-Authors
This is a "connection" page, showing publications co-authored by Elizabeth Graef and Jeffrey Sparks.
Connection Strength
2.658
-
Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al. Ann Rheum Dis. 2020 May 29.
Score: 0.884
-
Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al. Ann Rheum Dis. 2020 May 18.
Score: 0.883
-
Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666.
Score: 0.224
-
Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al. Ann Rheum Dis. 2020 Aug 07.
Score: 0.224
-
Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736.
Score: 0.219
-
Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'. Expert Rev Clin Immunol. 2021 01; 17(1):105-107.
Score: 0.057
-
Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Semin Arthritis Rheum. 2020 10; 50(5):1191-1201.
Score: 0.056
-
Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al. Ann Rheum Dis. 2020 Jul 09.
Score: 0.056
-
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821.
Score: 0.055